COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
The human body is a complex network of interconnected systems, and recent research has shed light on the intricate relationship between visceral adipose tissue (VAT), estradiol levels and cognitive health.
At the beginning of a new year, many people begin a detoxification and weight loss journey as part of their annual resolutions or to recover from over-indulging during the holidays. But in an environment where most are exposed to a variety of foreign contaminants daily, practices that help minimize or remove chemicals unknowingly stored in the body have become an important habit throughout the year.
Read how inflammation impacts the immune system and how diet and nutritional supplements can potentially help immune system functions.
Learn about the properties — including a biomarker for efficacy, known and unknown mechanisms of action and more — of minoxidil, the only FDA approved topical active pharmaceutical ingredient (API) for alopecia in men and women.
Polycystic ovary syndrome (PCOS) is the most prevalent hormonal disorder affecting women of reproductive age across the globe and the CDC estimates PCOS may be one of the most common causes of infertility. Learn how to help patients with PCOS.
Genitourinary syndrome of menopause (GSM), also known as vulvovaginal atrophy, is common among menopausal women. Learn more about GSM, relevant hormones and the importance of choosing the right base for compounding preparations.
Wellness Works Manager Stephanie Allen reviews nutritional supplements that may help women thrive.
Tricia Heitman of PCCA's Clinical Services Team discusses compounded treatment options for women suffering from atropic vaginitis, vluvar lichen sclerosis, desquamative inflammatory vaginitis, vaginismus, high-tone pelvic floor dysfunction and vulvodynia.
Maria Carvalho, Manager of PCCA Science, provides an in-depth look at the science behind Ellage, the first ever anhydrous compounding base developed specifically for vaginal delivery of medications.
With the debut of Ellage at International Seminar 2020, PCCA has introduced a revolutionary anhydrous vaginal base. Here are just a few of the exciting reasons why Ellage should be your pharmacy's go-to base when it comes to vaginal applications.